Mixed Hyperlipidemia

Mixed Hyperlipidemia is the indication for 5 drugs in DrugBank. It is covered by 11 curated, structured indications.

Also known as: type IIb Hypercholesterolemia · Mixed Hyperlipidaemia · Hyperlipoproteinemia Type IIb · Type IIb hyperlipoproteinaemia · Hyperlipidemia; Mixed
Classified under: Cholesterol
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lipids
Nutritional and Metabolic Diseases
Indicated drugs: Atorvastatin
Bezafibrate
Ezetimibe
Pitavastatin
Simvastatin

Resolves to

Vocabularies

MeSHM0486998ICD-10E78.2SNOMED CT154742006MedDRA10017345UMLSC0020474

What you can answer from here — as of October 22, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

11Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

28Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Mixed Hyperlipidemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.